Angiotech Pharmaceuticals, Inc.

Angiotech Pharmaceuticals to acquire Quill Medical

Published in Lab Law Weekly, June 23rd, 2006

Angiotech Pharmaceuticals, Inc., (ANPI, ANP) has entered into a definitive agreement to acquire privately held Quill Medical, Inc., a provider of specialized, minimally invasive aesthetic surgery and wound closure technology, for US$40 million in cash, plus certain future contingent payments based on product revenues.

Through this transaction, Angiotech will acquire all of Quill's technology and intellectual property, including the Contour Threads product line, which under its current license agreement is marketed and sold by Angiotech's Surgical Specialties division for use in aesthetic and cosmetic surgery.

"This acquisition allows us to capitalize...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2006-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry